Welcome to our dedicated page for Aurora Cannabis news (Ticker: ACB), a resource for investors and traders seeking the latest updates and insights on Aurora Cannabis stock.
Aurora Cannabis Inc. (ACB) is a globally recognized leader in medical and recreational cannabis production, operating advanced facilities that meet stringent international standards. This page serves as the definitive source for verified news and official announcements impacting ACB's market position and strategic initiatives.
Access real-time updates including quarterly earnings, regulatory compliance milestones, product launches, and partnership agreements. Investors will find essential details on operational expansions, while analysts gain insights into ACB's research-driven approach to cannabis cultivation and global distribution strategies.
Key coverage areas span clinical trial developments, international market entries, sustainability initiatives, and innovations in cannabis-derived health products. All content is curated to meet investor-grade reliability standards, sourced directly from company filings and accredited industry publications.
Bookmark this page for streamlined access to ACB's evolving narrative in the global cannabis sector. Combine our updates with Stock Titan's financial tools to monitor market reactions and long-term trends.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), a leading global medical cannabis company based in Canada, announced that it will host a conference call to discuss its fourth quarter and fiscal year 2024 results. The call is scheduled for Thursday, June 20, 2024, at 8:00 a.m. Eastern Time. The financial results for the quarter will be released before the market opens on the same day. Miguel Martin, CEO, and Simona King, CFO, will lead the call and a subsequent Q&A session. The webcast link can be accessed on the company's investor information page.
Aurora Cannabis, a leading medical cannabis company, has announced the launch of its premium 1.2g resin cartridges in Australia in partnership with MedReleaf Australia. These new products are now available for doctors to prescribe and are manufactured in Aurora's EU-GMP and TGA-GMP certified facilities.
The resin cartridges come under the Aurora and IndiMed brands, offering high-quality, full-spectrum options like Sourdough and Electric Honeydew. The products are designed to ensure exceptional flavor, potency, safety, and ease of use.
This move marks a significant expansion for Aurora, aiming to enhance patient access to premium cannabis in the Australian market.
Aurora Cannabis (NASDAQ: ACB; TSX: ACB) has appointed Rajesh Uttamchandani to its Board of Directors, effective May 15, 2024. Uttamchandani brings expertise in strategy development, innovation, human capital, and governance, with a background in senior roles at leading firms in technology, FinTech, and education sectors. His recent role was Chief People Officer at ApplyBoard, one of Canada's fastest-growing tech companies. Aurora's Chairman, Ron Funk, highlighted that Uttamchandani's experience aligns well with the company's strategic goals. Uttamchandani has served on boards of various organizations, including LifeSpeak and Ontario Cannabis Stores, and holds multiple advanced degrees and professional designations.
Aurora Cannabis Inc. marks the first shipment of medical cannabis products to the New Zealand market, showcasing premium, carefully crafted offerings. The company aims to redefine patient care by providing high-quality, potent products tailored to address various patient needs. The launch of these products signifies a significant milestone in improving medical cannabis accessibility in an emerging market like New Zealand.
Aurora Cannabis Inc. (ACB) and MedReleaf Australia have expanded their product offerings in Australia by introducing a new line of premium dried cannabis flower products. These products, including proprietary cultivars like Black Jelly, Chemango Kush, and Moon Berry, aim to provide patients with more choice and high-quality medical cannabis solutions. The expansion also includes the relaunch of the Vespera cultivar under the Aurora brand. The products are distributed by MedReleaf Australia, positioning itself as a leading distributor in the Australian market.
FAQ
What is the current stock price of Aurora Cannabis (ACB)?
What is the market cap of Aurora Cannabis (ACB)?
